Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;197(8):746-748.
doi: 10.1007/s00066-021-01796-z. Epub 2021 May 30.

[Effectiveness of sequential vs concurrent chemoradiation or radiation alone in the adjuvant treatment of cervical cancer after hysterectomy]

[Article in German]
Kilian Schiller  1 , Stephanie E Combs  2   3   4
Affiliations
Comment

[Effectiveness of sequential vs concurrent chemoradiation or radiation alone in the adjuvant treatment of cervical cancer after hysterectomy]

[Article in German]
Kilian Schiller et al. Strahlenther Onkol. 2021 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Sedlis A, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol. 1999;73(2):177–183. doi: 10.1006/gyno.1999.5387. - DOI - PubMed
    1. Peters WA, 3rd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606–1613. doi: 10.1200/JCO.2000.18.8.1606. - DOI - PubMed
    1. Monk BJ, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol. 2005;96(3):721–728. doi: 10.1016/j.ygyno.2004.11.007. - DOI - PubMed
    1. Moore DH. Chemotherapy for advanced, recurrent, and metastatic cervical cancer. J Natl Compr Canc Netw. 2008;6(1):53. doi: 10.6004/jnccn.2008.0006. - DOI - PubMed
    1. Monk BJ, et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a gynecologic oncology group study. J Clin Oncol. 2009;27(28):4649–4655. doi: 10.1200/JCO.2009.21.8909. - DOI - PMC - PubMed